FDA-approved dialysis drug may help fight against antimicrobial resistance

Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist the treatment. The answer to this antimicrobial resistance, which the Centers for Disease Control and Prevention called “one of the world’s most urgent public health problems,” might be a medication used for kidney disease, according to a team led by researchers at Penn State.